Company Filing History:
Years Active: 2018
Title: Gansukh Enkhtaivan: Innovator in Antiviral Composition
Introduction
Gansukh Enkhtaivan is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antiviral compositions. His work is aimed at addressing viral diseases, which pose a considerable threat to public health.
Latest Patents
Gansukh holds a patent for an antiviral composition that includes materials involved in the phosphatidylcholine synthesis pathway. The invention comprises a selection from chlorine, phosphocholine, cytidine triphosphate, CDP-choline, phosphorylcholine, and phosphatidylcholine. This antiviral composition is designed to be harmless to the human body while exhibiting an excellent inhibitory effect on virus proliferation. It has potential applications in pharmaceutical compositions for preventing or treating viral diseases, as well as in health functional foods, quasi-drug compositions, and feed compositions aimed at preventing or ameliorating viral diseases. He has been granted 1 patent for this innovative work.
Career Highlights
Gansukh is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he continues to advance his research in biotechnology. His work is characterized by a commitment to developing safe and effective solutions for viral infections.
Collaborations
Gansukh collaborates with talented colleagues, including Dur Han Kwon and Mi Jin Jang, who contribute to the innovative environment at the Korea Research Institute of Bioscience and Biotechnology.
Conclusion
Gansukh Enkhtaivan's contributions to antiviral research highlight the importance of innovation in combating viral diseases. His work not only showcases his expertise but also reflects a broader commitment to public health and safety.